From the FDA (United States)-approved E. chrysanthemi L-asparaginase, Nguyen et al. (2018) created a novel low glutaminase enzyme that was highly effective against T and B cell ALL (Nguyen et al., 2018). Here, ASPG is linked to acute lymphoblastic leukemia.